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Abstract: Toxoplasma gondii is a cosmopolitan protozoon parasite, and the causative agent of toxo-
plasmosis, one of the most prevalent zoonotic parasitic diseases. Cats, as definitive hosts, spread the
parasite via their faeces, but this occurs only for a very short period in their life. Seropositivity in
cats, although not associated with current shedding of the parasite, is indicative of the infection in a
cat population and can be used to assess the infection risk for definitive and intermediate hosts in
that area. In order to assess the prevalence of infection in cats living in Cyprus, 155 cats, originating
from all districts of the country, were examined for the presence of T. gondii antibodies. Additionally,
parameters such as age, sex, health status, lifestyle and concomitant infections were statistically
assessed as potential risk factors for T. gondii seropositivity. Specific anti-T. gondii antibodies were
detected in 50 (32.3%) cats, while the presence of feline immunodeficiency virus antibodies and a
history of never having been vaccinated were statistically associated with T. gondii seropositivity on
multivariate logistic regression analysis. This is the first report of T. gondii seroprevalence in cats
in Cyprus and indicates that raised public awareness should be considered to prevent infection of
animals and humans.
Keywords: Cyprus; domestic cat; seroprevalence; Toxoplasma gondii
1. Introduction
The apicomplexan protozoon Toxoplasma gondii is one of the most extensively studied
zoonotic parasites. It has a heteroxenous lifecycle that was fully described in 1970, when
several different groups of investigators identified the domestic cat (Felis catus) as the defini-
tive host [1]. The parasite passes its sexual, enteroepithelial phase in felids, and spreads
into the environment in the form of environmentally resistant oocysts, shed through the
faeces of infected felids. Sporulated oocysts, which develop from immature oocysts a few
days after their excretion in cat faeces, are the infective stage for intermediate hosts, which
comprise virtually all warm-blooded animals and humans [2,3]. Generally, both definitive
and intermediate hosts may be infected (a) horizontally, by ingesting sporozoites in sporu-
lated oocysts from the environment or by consuming bradyzoites and/or tachyzoites in
tissue cysts in infected intermediate hosts, and (b) vertically, by transplacentally (or/and
lactogenically in some species, e.g., goats, cats) transmitted tachyzoites [3,4].
Toxoplasma gondii infection usually remains subclinical in cats, although vertical toxo-
plasmosis or infection in immunocompromised cats may cause severe disease and even
death [5]. Conversely, toxoplasmosis is considered one of the most important causes of
abortion and, thus, of economic losses in livestock, particularly sheep and goat farming.
Furthermore, toxoplasmosis has important zoonotic implications and infects, by estimation,
nearly one third of the global human population [6], as one of the main foodborne diseases
causing death [7].
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At any given time, approximately 0.1–1% of cats are expected to shed oocysts, based
on the observation that most cats only shed oocysts for about 1–2 weeks in their life [8,9].
However, in this short period of time, a cat can excrete millions of oocysts, which can
remain infective in the environment for months and infect many hosts [10]. Diagnosis of
infection in cats can be attempted by copromicroscopic examination; however this is not a
helpful approach as (i) the enteroepithelial phase is very short, and (ii) other oocysts with
indiscriminate morphology, i.e., species of the genera Hammondia and Besnoitia, can occur
in cat faeces, necessitating molecular identification of the parasite [9].
Cats seroconvert approximately 1–2 weeks after the end of the enteroepithelial phase;
thus, a seropositive cat no longer sheds oocysts [11]. Although seropositivity for T. gondii
antibodies does not indicate that the cat is currently shedding the parasite, and not all
seropositive cats have shed oocysts in the past [12,13], seroepizootiological studies are a
useful indicative of infection in an area and a given cat population, and can be used to
assess the infection risk for definitive and intermediate hosts in that same area [14].
Seroprevalance for T. gondii in domestic cats is estimated to be between 30 and 40%,
worldwide [1]; however, depending on geography and sample size, seroprevalence has
varied between 4.8% and 100.0% [5]. Although several reports on seroprevalence in cats
have been published, there is still a paucity of information in many regions and countries
of the world. The Republic of Cyprus is an islandic state in the eastern Mediterranean Sea,
with a large number of cats, both pets and free-roaming or stray, that are often infected
with multiple pathogens [15–17]. In this country, a limited number of surveys investi-
gating the prevalence of T. gondii infection in humans and intermediate hosts have been
reported [18,19]. However, the prevalence of infection in cats has never been investigated.
In this context, the aim of the present study was to investigate the seroprevalence of T. gondi
infection in cats from Cyprus, and to explore possible risk factors associated with seroposi-
tivity in cats. We report a seroprevalence of 32.3% of anti-T. gondii IgG in this population of
cats and that a lack of vaccination and the presence of feline immunodeficiency virus (FIV)
antibodies were associated with T. gondii seropositivity.
2. Materials and Methods
2.1. Study Design, Site Populations and Sampling
Blood samples of cats, both healthy and clinically ill, living in all six districts of
Cyprus, i.e., Famagusta, Kyrenia, Larnaca, Limassol, Nicosia and Paphos, were collected
in veterinary clinics from March to September 2014 as part of a previous study [17]. The
samples were collected by the attending veterinarians during clinical routine examinations
for healthy cats or medical checks for ill cats. Aliquots of 155 serum samples were used
in the present study with the informed written consent of cat owners or animal shelter
managers. For every cat, data concerning district of origin, habitat (rural or urban), age
(≤1 year or >1 year, on the basis of health records), sex, breed, housing (access to outdoors
or indoors only living), lifestyle (sheltered-stray or owned cat), previous travel history
outside Cyprus, health status and vaccination status, use of ectoparasitic prevention and
presence of anaemia (haematocrit <25%) based on in-house complete blood count were
recorded. The serum samples were stored at −80 ◦C until they were transferred to the
Laboratory of Parasitology and Parasitic Diseases, School of Veterinary Medicine, Aristotle
University of Thessaloniki, Greece for examination.
2.2. Serological Examination
The serum samples were examined with the commercial kit ID Screen® Toxoplasmosis
Indirect Multi-species ELISA (ID.vet, Grabels, France), which detects anti-T. gondii IgG
antibodies. The kit, which uses a purified peptide of the main P30 T. gondii protein as a
substrate and a multi-species peroxidase (po) as conjugates, has shown a high level of
concordance with other serological tests, and has been proved useful for toxoplasmosis
serological screening in cats [20]. The test was performed following the manufacturer’s
instructions. Briefly, for each sample, the sample to positive ratio (s/p %) was calculated
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ODpc − ODnc × 100
Samples with an s/p% ≤ 40% were considered negative, between 40% and 50% were
considered doubtful and ≥50% were considered positive.
Additionally, in the framework of a previously published study [17], all samples under-
went retroviral serology testing using PetCheck FeLV Antigen Test and PetCheck FIV Antibody
Test (IDEXX Laboratories, Westbrook, ME, USA), Leishmania infantum antibody testing as well
as PCR for Bartonella henselae, “Candidatus Mycoplasma haemominutum” (CMhm), “Candidatus
Mycoplasma turicensis” (CMt) Ehrlichia/Anaplasma spp., Hepatozoon spp., Leishmania spp.,
and Mycoplasma haemofelis (Mhf).
2.3. Data Analysis
Univariate analysis was performed to evaluate for associations between seropositivity
for T. gondii and demographic characteristics, as well as multiple co-infecting pathogens.
Pearson’s Chi-square test was performed for the categorical variables. Variables with a
trend towards significant association with T. gondii seropositivity (p-value < 0.2) were
selected for further analysis with multivariate logistic regression. For the final model, a
backward selection was used, and once a final model was structured, all the previously
excluded variables were then individually retested and, if then significant, were included
in the final model. For both the univariate and multivariate models, a p-value ≤ 0.05
was considered statistically significant. Statistical analysis was performed using SPSS for
Windows (version 25.0; SPSS Inc., Chicago, IL, USA).
3. Results
Of the 155 examined samples, 50 (32.3%) were positive for T. gondii antibodies, with
the remainder yielding negative results. At a district level, the percentage of seropositive
cats was in Paphos 33.0%, Limassol 24.0%, Nicosia 36; 0%, Larnaca 31.0%, Kyrenia 40.0%,
and Famagusta 29.0% (Figure 1). The age of seropositive cats ranged from 0.7 to 22.0 years
(median 5.1 years, interquartile range 8 years), with 81 (52.3%) being male and 143 (92.3%)
being non-pedigree cats. Tables 1 and 2 show the demographic characteristics of this feline
population, as well as the seroprevalence of T. gondii among the multiple co-infecting
pathogens. The entire data set can be found in Supplementary File 1.




Figure 1. Toxoplasma gondii seropositivity in cats from the different districts of Cyprus. 
Table 1. Comparison of Toxoplasma gondii seropositivity and univariable analysis in cats from Cy-
prus per non-infectious categorical variable. 
Variable (No. of 
Records) 
No. of Cats (%) 
T. gondii Seropositive Cats 
No. (% ± 95% CI) p-Values 
Age (155)    
≤1 year 17 (11.0) 3 (17.6 ± 18.1) 0.172 
>1 year (Ref.) 138 (89.0) 47 (34.1 ± 7.9)  
Gender (155)    
Male 81 (52.3) 25 (30.9 ± 10.0) 0.698 
Female (Ref.) 74 (47.7) 26 (33.8 ± 10.7)  
Breed (155)    
Non-Pedigree 143 (92.3) 49 (34.3 ± 7.7) 0.065 
Pedigree (Ref.) 12 (7.7) 1 (8.3 ± 15.6)  
Housing (155)    
Access to outdoors 119 (76.8) 43 (36.1 ± 12.9) 0.061 
Indoors only (Ref.) 36 (23.2) 7 (19.4 ± 12.9)  
Lifestyle (155)    
Shelter-feral 32 (20.6) 13 (40.6 ± 17.0) 0.256 
Owned (Ref.) 123 (79.4) 37 (30.1 ± 8.1)  
District (155)    
Paphos (Ref.) 54 (34.8) 18 (33.3 ± 12.6) 0.280 
Nicosia 42 (27.1) 15 (35.7 ± 14.5)  
Larnaca 26 (16.8) 8 (30.8 ± 17.7)  
Limassol 21 (13.5) 5 (23.8 ± 18.2)  
Famagousta 7 (5.0) 2 (28.6 ± 33.5)  
Kyrenia 5 (3.2) 2 (40.0 ± 42.9)  
Habitat (155)    
Figure 1. Toxoplasma gondii seropositivity in cats from the different districts of Cyprus.
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Table 1. Comparison of Toxoplasma gondii seropositivity and univariable analysis in cats from Cyprus
per non-infectious categorical variable.
Variable (No. of Records) No. of Cats (%)
T. gondii Seropositive Cats
No. (% ± 95% CI) p-Values
Age (155)
≤1 year 17 (11.0) 3 (17.6 ± 18.1) 0.172
>1 year (Ref.) 138 (89.0) 47 (34.1 ± 7.9)
Gender (155)
Male 81 (52.3) 25 (30.9 ± 10.0) 0.698
Female (Ref.) 74 (47.7) 26 (33.8 ± 10.7)
Breed (155)
Non-Pedigree 143 (92.3) 49 (34.3 ± 7.7) 0.065
Pedigree (Ref.) 12 (7.7) 1 (8.3 ± 15.6)
Housing (155)
Access to outdoors 119 (76.8) 43 (36.1 ± 12.9) 0.061
Indoors only (Ref.) 36 (23.2) 7 (19.4 ± 12.9)
Lifestyle (155)
Shelter-feral 32 (20.6) 13 (40.6 ± 17.0) 0.256
Owned (Ref.) 123 (79.4) 37 (30.1 ± 8.1)
District (155)
Paphos (Ref.) 54 (34.8) 18 (33.3 ± 12.6) 0.280
Nicosia 42 (27.1) 15 (35.7 ± 14.5)
Larnaca 26 (16.8) 8 (30.8 ± 17.7)
Limassol 21 (13.5) 5 (23.8 ± 18.2)
Famagousta 7 (5.0) 2 (28.6 ± 33.5)
Kyrenia 5 (3.2) 2 (40.0 ± 42.9)
Habitat (155)
Rural 59 (38.1) 23 (39.0 ± 12.4) 0.160
Urban (Ref.) 96 (61.9) 27 (28.1 ± 8.9)
Travel history (155)
Never travelled abroad 141 (91.0) 45 (31.9 ± 7.7) 0.772
Travelled abroad (Ref.) 14 (9.0) 5 (35.7 ± 25.0)
Health status (155)
Non-healthy 115 (74.2) 39 (33.9 ± 8.6) 0.455
Healthy (Ref.) 40 (25.8) 11 (27.5 ± 13.8)
Vaccination status (146)
Never vaccinated 41 (28.1) 19 (46.3 ± 15.2) 0.016
Vaccinated (Ref.) 105 (71.9) 27 (25.7 ± 8.3)
Ectoparasite prevention (146)
Never applied 56 (38.4) 24 (42.9 ± 12.9) 0.020
Applied (Ref.) 90 (61.6) 22 (22.4 ± 8.6)
Haematocrit (118)
Anaemic 28 (23.7) 11 (39.3 ± 18.0) 0.358
Non-anaemic 90 (76.3) 27 (30.0 ± 9.5)
p-values < 0.2 but > 0.05 are shown in italics. Significant p-values ≤ 0.05 are shown in bold; CL: Confidence
interval; Ref: Reference category.
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Table 2. Comparison of Toxoplasma gondii seropositivity and univariable analysis in cats from Cyprus
with different co-infective agents.
Variable (No. of Records) No. of Cats (%)
T. gondii Seropositive Cats
No. (% ± 95% CI) p-Values
FeLV antigen (152)
Positive 9 (5.9) 1 (11.1 ± 20.5) 0.152
Negative (Ref.) 143 (94.1) 49 (34.3 ± 7.8)
FIV antibody (152)
Positive 27 (17.8) 18 (66.7 ± 17.7) <0.0001
Negative (Ref.) 125 (82.2) 32 (25.6 ± 7.6)
Any haemoplasma PCR (155)
Positive 39 (25.2) 16 (41.0 ± 15.4) 0.678
Negative (Ref.) 116 (73.8) 34 (29.3 ± 8.3)
Mhf PCR (155)
Positive 10 (6.5) 4 (40.0 ± 30.4) 0.588
Negative (Ref.) 145 (93.5) 46 (31.7 ± 7.6)
CMhm PCR (155)
Positive 31 (20.0) 14 (45.2 ± 17.5) 0.086
Negative (Ref.) 124 (80.0) 36 (29.0 ± 7.9)
CMt PCR (155)
Positive 9 (5.8) 3 (33.3 ± 30.8) 0.943
Negative (Ref.) 146 (94.2) 47 (32.2 ± 7.6)
Any FVBP PCR (155)
Positive 73 (47.1) 29 (39.7 ± 11.2) 0.061
Negative (Ref.) 82 (52.9) 21 (25.6 ± 9.4)
L. infantum infection * (155)
Positive 12 (7.7) 3 (25.0 ± 24.5) 0.576
Negative (Ref.) 143 (92.3) 47 (32.9 ± 7.7)
B. henselae PCR (155)
Positive 16 (10.3) 7 (43.8 ± 24.3) 0.576
Negative (Ref.) 139 (89.7) 43 (30.9 ± 7.7)
Hepatozoon spp. PCR (155)
Positive 62 (40.0) 26 (41.9 ± 12.3) 0.035
Negative (Ref.) 93 (60.0) 24 (25.8 ± 8.9)
p-values < 0.2 but > 0.05 are shown in italics. Significant p-values ≤ 0.05 are shown in bold; Any haemoplasma
PCR: Positivity in at least one of the following haemoplasma PCRs: Mhf, CMhm and CMt; CI: Confidence interval;
CMhm: “Candidatus Mycoplasma haemominutum”; CMt: “Candidatus Mycoplasma turicensis”; FeLV: feline
leukaemia virus; FIV: feline immunodeficiency virus; FVBP: Feline Vector Borne Pathogen—positive for at least
one of the PCRs for B. henselae, Ehrlichia/Anaplasma spp. and/or Hepatozoon spp., and/or L. infantum infection;
Mhf: Mycoplasma haemofelis; Ref: Reference category; * L. infantum infection: confirmed by DNA sequencing
following confirmatory qPCR and/or positive ELISA.
Univariate analysis (Tables 1 and 2) revealed significant associations (p ≤ 0.05) be-
tween T. gondii seropositivity and the followings factors: never vaccinated, no application
of ectoparasitic prevention, seropositivity for FIV, and positive Hepatozoon spp. PCR. Addi-
tionally, a trend toward significance (p < 0.2) for T. gondii seropositive was noted for cats
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that were non-pedigree, had outdoor access, lived in a rural area, were PCR-positive for
CMhm and PCR-positive for at least one feline vector borne pathogen (FVBP).
A multivariate logistic regression model (Table 3) was constructed and yielded sig-
nificant associations (p ≤ 0.05) for T. gondii seropositive that included FIV seropositivity
(odds ratio (OR) = 5.0, 95% confidence interval (CI): 2.0–13.0, p = 0.001) and never being
vaccinated (OR = 2.5, 95% CI: 1.2–5.7, p = 0.019).
Table 3. Multivariate logistic regression models regarding Toxoplasma gondii seropositivity in cats
from Cyprus.
Odds Ratio (95% CI) p-Value
FIV antibody
Positive 5.0 (2.0–13.0) 0.001
Negative Ref.
Vaccination status
Never vaccinated 2.6 (1.2–5.7) 0.019
Vaccinated Ref.
CI: Confidence interval; Ref: Reference category; FIV: feline immunodeficiency virus; Significant p-values ≤ 0.05
are shown in bold.
4. Discussion
Toxoplasma gondii is a prevalent parasite and toxoplasmosis affects a wide range of
animals, both wild and domestic. Clinical toxoplasmosis in cats is rare; however it can occur
in congenital infections that can be fatal, or postnatal infections in immunosuppressed
cats, mainly involving the central nervous system and, less often, other organs, such as the
lungs and eyes [21]. Farmed small ruminants, i.e., sheep and goats, are susceptible species,
where toxoplasmosis is one the most important and prevalent causes of abortion, greatly
affecting production and causing economic losses [22]. In Cyprus, the seroprevalence of
T. gondii infection in small ruminants (sheep and goats) was found to be 40.1% in a recent
survey [19].
Human toxoplasmosis in immunocompetent individuals usually remains asymp-
tomatic, but rarely, it may cause a flu-like syndrome with fever, lymphadenopathy, hep-
atosplenomegaly and ocular lesions [23]. The most important implications of human
toxoplasmosis are in immunosuppressed individuals, who can develop severe and even
fatal disease, and in congenital infections that, depending on the gestational age at infec-
tion, can have a wide range of outcomes, from abortion to birth of asymptomatic infected
infants [24,25]. In Cyprus, T. gondii seroprevalence in humans has been investigated in two
groups of females: 16–18-year-old girls and pregnant women, showing prevalences of 6.5%
and 18.0%, respectively [19]. A system for the epidemiological surveillance of symptomatic
toxoplasmosis, both congenital or post-natal, has been employed in Cyprus since 2004 [26].
Nevertheless, there is evidence that such cases are still underreported [19].
In an epidemiological survey that took place in the early 2010s in several areas in
Cyprus, Paphos displayed the highest seroprevalence in girls and women compared to
the other districts of Cyprus [19]. However, in our study’s results, the seroprevalence in
cats in Paphos was not higher than in other areas. This is not necessarily a contradictory
observation, as the main mode of human infection by T. gondii is via consumption of raw
or undercooked infected meat, or via ingestion of sporulated oocysts found on unwashed
fruits and vegetables. Both ways of transmission involve foodstuffs that are moved from
other areas of Cyprus, and are not related to contact with local contaminated soil [27]. In
our present study, all districts of Cyprus displayed similar rates of feline infection, which is
not surprising as there are no boundaries on the island that could isolate cat populations
and, similarly, the intermediate hosts playing a key role in feline infection (rodents and
birds) are abundant in all districts, and have been found to have a high percentage of up to
27.9% of seropositivity [18].
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Cats are abundant in Cyprus, both as owned pets and as strays and, according to
recent estimations, their population has reached 1.5 million [28]. Surveys investigating
infectious and parasitic diseases of Cyprus cats are scant [15,17]. The current study is the
first serological investigation of T. gondii infection in cats in Cyprus. Such surveys are
needed to monitor the occurrence of this important pathogen in a given region and to
predict the risk of infection in farm animals and humans [14].
In Europe, several T. gondii seroprevalence studies in feline populations have been
conducted over the last decade [5]. The result of the present survey shows that the infection
rate in Cyprus (32.3 %) is consistent with the recently reported prevalences in most areas
in Europe, even though in some countries, such as Poland, France, Estonia and Albania,
percentages of over 60.0% have been recorded [29–33]. During the last decade, the highest
percentage of seropositive animals (84.7%) was recorded in the island of Majorca, in feral
cats [34]. In areas of continental Spain, T. gondii seroprevalence was recorded as 36.9%
in stray, 33.3% in farm and 25.5% in pet animals [35]. Interestingly, the lowest T. gondii
seroprevalence in Europe was found in a breeding Persian cat colony, at 10.0% [36]. The
latter indicates that cats living in a family household, without outdoor access, can still be
infected, most probably by feeding of raw meat and less probably by ingesting infective
oocysts that are mechanically transported in the house on the shoes or on arthropods [13].
Indeed, T. gondii is adapted to a tissue cyst-oral route of transmission in cats, as it has been
shown that one tissue cyst is a competent infective dose, while 100 or more sporulated
oocysts may be required to establish infection in a cat [37]. Accordingly, less than 50% of
cats acquire a patent infection after ingesting oocysts, while almost all eliminate oocysts
after tissue cyst consumption [22]. Similar to the lifestyle types evidenced as risk factors for
T. gondii in previous surveys, the results of the present study show that cats with a likely
lower veterinary care profile i.e., never vaccinated and without ectoparasite prevention,
were significantly more likely to be seropositive. Furthermore, cats that had outdoor access,
and cats that lived in a rural area, had a trend towards a statistically significant higher
infection percentage than the cats with an indoor lifestyle or living in urban environment,
respectively. This finding could be associated with the opportunity of a cat to prey on
intermediate hosts (e.g., rodent or bird), which may occur more frequently for cats with
outdoor access or living in rural areas. For these obvious reasons, outdoor access and living
in peri-urban areas were also identified as risk factors for T. gondii infection in previous
studies [13,35,38–41]. Accordingly, the association found in the present study between
Hepatozoon spp. and T. gondii infection, using univariate analysis, is most likely related to
the inadequate veterinary care and lack of ectoparasites prevention that usually occurs in
cats with the above-mentioned lifestyle characteristics.
Age was not identified as a risk factor in the present study, despite there being a
trend towards a significant association with seropositivity for cats more than one year of
age compared to cats of one year of age or younger. Seroconversion in cats takes place
3–4 weeks post-infection and seropositivity lasts practically for all their lives, making age
association an expected feature due to the accumulation of infection in older cats [31,42].
However, the fact that most cats are infected young, on their early hunting expeditions,
abolish age-dependence after the first months of the animals’ life. Similarly, sex was also
not associated with T. gondii seroprevalence in the present survey, as was also the case in
several previous studies [42–44]. However, sex has been related with infection risk in some
reports, with females found to be more prevalently infected than males [38], or with males
being infected at a higher rate, but only when the studied cats had outdoor access [45].
Nevertheless, sex has an unclear relation to T. gondii infection prevalence.
In the present study, a significant association between FIV infection and seropositivity
to T. gondi was found in the final multivariate logistic regression model. It has been sug-
gested that immunosuppression associated with feline leukaemia virus (FeLV) and FIV
infection may predispose cats to toxoplasmosis [46–48]. However, in some surveys, no asso-
ciation with these two retroviral infections has been documented [46,49]. The results of the
present study are in accordance with most epizootiological surveys, which have evidenced
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that it is mainly FIV, rather that FeLV, that is correlated with Toxoplasma infection [41,42,50].
The immunodeficiency caused by FIV infection is most likely the underlying cause of cats’
enhanced susceptibility to Toxoplasma infection and for the antigenaemia and increased
antibody synthesis resulted by the proliferation of cyst bradyzoites in already infected cats,
facilitated by the impact of the viral infection [51,52].
CMhm infection showed a trend toward significance for T. gondii seropositivity but
did not yield a significant association under multivariate logistic regression analysis. In
accordance with the present results, in a survey in Albania, a higher percentage of cats
were simultaneously infected with haemoplasmas and T. gondii than with haemoplasmas
only, but the association was non-significant [31]. A possible association between common
haemoplasmas infecting cats and susceptibility to T. gondii infection is worth further
investigation in the future.
Toxoplasma gondii represents an important agent in terms of disease and of zoonotic
impact and economic implications in animal production. For these reasons, there is great
merit in monitoring its epizootiological/epidemiological trends. In Cyprus, further studies
in more animal species and an investigation of the factors involved in human infection
are warranted to form a clearer image of infection prevalence and risk factors. Finally,
raising public awareness of the ways to prevent T. gondii infection of animals and humans
is pivotal in terms of the One Health concept.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10.3
390/pathogens10070882/s1, The Supplementary File 1 has all the datasets supporting the findings of
this study.
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29. Michalski, M.M.; Platt-Samoraj, A.; Mikulska-Skupień, E. Toxoplasma gondii antibodies in domestic cats in Olsztyn urban area,
Poland. Wiad. Parazytol. 2010, 56, 277–279.
30. Afonso, E.; Germain, E.; Poulle, M.-L.; Ruette, S.; Devillard, S.; Say, L.; Villena, I.; Aubert, D.; Gilot-Fromont, E. Environmental
determinants of spatial and temporal variations in the transmission of Toxoplasma gondii in its definitive hosts. Int. J. Parasitol.
Parasites Wildl. 2013, 2, 278–285. [CrossRef]
31. Silaghi, C.; Knaus, M.; Rapti, D.; Kusi, I.; Shukullari, E.; Hamel, D.; Pfister, K.; Rehbein, S. Survey of Toxoplasma gondii and
Neospora caninum, haemotropic mycoplasmas and other arthropod-borne pathogens in cats from Albania. Parasites Vectors 2014,
7, 62. [CrossRef]
32. Must, K.; Lassen, B.; Jokelainen, P. Seroprevalence of and Risk Factors for Toxoplasma gondii Infection in Cats in Estonia. Vector
Borne Zoonotic Dis. 2015, 15, 597–601. [CrossRef]
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